CDC, hepatitis B
Digest more
As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that policymakers set clear elimination targets for hepatitis B, coordinate efforts, enhance surveillance, and create supportive regulatory environments to support this.
Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral replication but rarely achieving functional cure. Adaptive immunity is central to viral clearance but is profoundly impaired during chronic infection.
Chronic hepatitis B occurs when the body cannot eliminate the hepatitis B virus following an acute infection. Having chronic (or lifelong) hepatitis B can increase a person’s risk of developing advanced liver disease, such as cirrhosis. Diagnosing ...
Hosted on MSN
Understanding If There’s a Cure for Hepatitis B
When news broke in 2014 that hepatitis C, a viral disease affecting the liver, could be cured thanks to a new class of direct-acting antiviral drugs, many began to wonder how soon it would be before the same occurred with its cousin, hepatitis B.
The influenza season marks the beginning of a time of illness, sometimes serious or even fatal, in much of the world. For this reason, flu shots are recommended, especially for individuals with underlying diseases such as chronic hepatitis B (CHB ...
Children and infants can contract hepatitis B. Some children may recover without treatment and have no long-term effects, but for others it can turn into a lifelong infection. Hepatitis B is a liver infection that results from a virus. It can be acute ...
HepatitisB paper The approval was supported by data from a phase 2 trial that included 70 patients aged 12 to less than 18 years with chronic HBV infection. The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA ...
Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the childhood vaccine schedule, potentially delaying a dose of the hepatitis B vaccine given to newborns by weeks or even years.